Strength
1 mg/mL
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710141101
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
3/19/2025
Active Ingredients
BORTEZOMIBApproval Type
Generic (ANDA)
FDA Application
ANDA210204On Market Since
5/2/2022
Pharmacological Classes
Proteasome Inhibitor
Proteasome Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
BORTEZOMIB 3.5 MG VIAL
Generic
00143909801•Hikma Pharmaceuticals USA Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
00409170001•Hospira Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
31722030331•Camber Pharmaceuticals Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
43598042660•Dr. Reddy's Laboratories Inc.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
50742048401•Ingenus Pharmaceuticals LLC
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
60505605004•Apotex Corp.
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
63323082110•Fresenius Kabi USA, LLC
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
68001053436•BluePoint Laboratories
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
68001054036•BluePoint Laboratories
$43.3460
per EA
BORTEZOMIB 3.5 MG VIAL
Generic
68001054136•BluePoint Laboratories
$43.3460
per EA